North America Breast Implants Market size was valued at USD 738.6 million in 2018 and is expected to witness 9.4% CAGR from 2019 to 2025.
North America Breast Implants Market, By Product, 2018 & 2025 (USD Mn)
Growing incidence of breast cancer will positively influence North America breast implants market growth in the foreseeable future. According to the American Society of Plastic Surgeons (ASPS), over 1.8 million cosmetic surgery procedures were performed in 2017, out of which breast augmentation had highest share. Thus, growing need regarding enhancement of breast will lead to increasing demand for breast implants in North America over the coming years.
Increasing awareness towards breast implants will offer lucrative market growth potential over the future years. Improvement in perception for cosmetic surgeries augments adoption rate of breast implants. Also, benefits like better psychosocial and sexual well-being, improved quality of life and risen satisfaction with breast appearance should lead to significant North America Breast Implants market growth during the upcoming years.
Growing desire to look attractive has resulted in greater number of women opting for breast augmentation procedures for improving their breast size and shape which drives market growth. Technological developments in breast implants such as changes in design, material and fill volumes resulting in reduction of problems of wrinkling and rippling should further stimulate adoption. Rising number of skilled plastic surgeons required for conducting these procedures along with providing valuable consultation to patient will further boost growth.
Silicone breast implants market held significant revenue size of USD 688.2 million in 2018. These breast implants provide natural appearance, less wrinkling and decreased risk of downward displacement. Hence, above mentioned reasons will accelerate the adoption of silicone breast implants among patients for desired results in the upcoming period.
Saline breast implants is estimated to witness considerable progress at 8.6% CAGR over the forecast timeframe. Requirement of smaller incision during the implantation process will boost the implants’ adoption rate. Capability of the implants to be filled and adjusted during the procedure providing scope for increasing or decreasing volume for improved breast symmetry will further stimulate the product demand.
Round breast implants segment contributed is estimated to grow with a promising CAGR of 9.7% in the forecast period. Round breast implants are fluid and acquire shape of natural breasts. Moreover, these breast implants create properly proportioned breasts. These properties of round breast implants will augment the segmental growth.
Anatomical breast implants market will grow at robust 7.4% CAGR during the forecast period. In addition to aesthetically fuller and firmer look to the breasts, anatomical implants are also used for breast lift, restoration of lost breast volume after breast feeding and balancing asymmetries. Hence, increasing application of anatomical breast implants will spur the product demand, thereby boosting the market growth.
Breast reconstruction segment is estimated to grow at momentous pace of 9.2% CAGR over the forecast timeframe. Breast reconstruction caters to increasing demand from women affected by breast cancer as the procedure restores breast volume and aesthetics after mammoplasty. With increasing incidence of breast cancer, breast reconstruction segment will grow lucratively in the foreseeable future. As per GLOBOCAN, in 2015, there were 292,130 new cases of breast cancer in U.S. female population. Moreover, factors such as aging, personal or family history of breast cancer, exposure to radiation, obesity and consumption of alcohol increases the risk of acquiring the breast cancer, that will further drive breast reconstruction market growth.
Smooth breast implants segment is estimated to grow at a lucrative CAGR of 10.0% during the projected period. The growth is attributed to the advantageous properties of smooth breast implants like free movement with natural activities and sleek appearance that will favour customer preference, hence driving the segmental growth.
Textured breast implant market accounted for over USD 615.7 million in 2018. Textured breast implants have been developed recently for stabilization and reduction of capsular contracture. Attachment of these breast implants to the tissue capsule does not allow the implants to move that increases the preference for textured implants. In addition, increasing demand for breast reconstruction and rising incidence of breast cancer will spur textured implants market share in the forthcoming years.
Clinics segment is expected to grow with the highest CAGR by end-use in the forecast period. This growth is owing to shorter procedural time as compared to hospitals along with availability of skilled resources. Also, specific attention is provided to patients in clinincs.
Hospitals segment will witness lucrative growth at 9.0% CAGR over the forecast timeframe. Hospitals as a healthcare setting provide a wide variety of diagnostic, curative and rehabilitation services. Hospitals are much larger as compared to clinics and ambulatory surgical centers as well as have a well-organized medical, nursing and other healthcare professional staff. Hence, greater safety and care provided in hospitals will further boost influx of patients for breast implantation procedures in hospitals over the coming years.
U.S. Breast Implants market accounted USD 699.6 million in 2018 and is forecasted to progress at rapid pace over the projected period. Adoption of cutting edge technology along with well-established healthcare infrastructure will aid U.S. breast implants market growth. Presence of major market players operating in breast implants market that offer advanced and quality breast implants services in the country will highly impact demand for breast implants. Furthermore, increasing expenditure on cosmetic procedures will boost U.S. breast implants industry growth over the forecast timeframe.
Some of the major industry players involved in North America breast implants market include Sientra, Mentor worldwide LLC, Ideal Implant Inc, Establishment Labs SA, Allergan Plc, Laboratory Arion, Cereplas and GC Aesthetics. These firms are adopting inorganic growth strategies such as partnerships, collaborations and new product launches to gain competitive edge over other market players. For instance, in October 2017, Mentor announced the availability of MemoryGel silicone-gel filled breast implants. This strategy will help the firms in expanding their customer base as well as grow financially.
In 1976, the U.S. Food and Drug Administration (FDA) regulated silicone breast implants, subjecting them to controls and performance standards. In 1992, the FDA advises that silicone breast implants should only be used for reconstruction after surgery or to correct congenital deformities. In 2006, the FDA lifts its restrictions on silicone breast implants, clearing them for cosmetic use in women aged from 22. Meanwhile, large number of companies in North America, entered this business. Perception towards cosmetic surgeries improved over time. At present, breast implantation is one of highest opted cosmetic surgery.
In future years, growing number of cosmetic surgeries and lowering cost of breast implants will facilitate better cost-effectivity and thereby, drive the breast implants industry growth. Furthermore, growing technological advancements in breast implantation will provide immense breast implants market expansion opportunities in the foreseeable future.